324 related articles for article (PubMed ID: 37242462)
1. Rosiglitazone Does Not Affect the Risk of Inflammatory Bowel Disease: A Retrospective Cohort Study in Taiwanese Type 2 Diabetes Patients.
Tseng CH
Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242462
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone Has a Null Association with Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus.
Tseng CH
Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36558989
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis.
Tseng CH
BMC Cancer; 2022 May; 22(1):559. PubMed ID: 35585577
[TBL] [Abstract][Full Text] [Related]
4. Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus.
Tseng CH
J Crohns Colitis; 2021 Jan; 15(1):64-73. PubMed ID: 32604412
[TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone has a neutral effect on the risk of dementia in type 2 diabetes patients.
Tseng CH
Aging (Albany NY); 2019 May; 11(9):2724-2734. PubMed ID: 31085804
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone Reduces Dementia Risk in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Analysis.
Tseng CH
J Clin Med; 2018 Sep; 7(10):. PubMed ID: 30262775
[TBL] [Abstract][Full Text] [Related]
7. Metformin use is associated with a reduced risk of acute appendicitis in Taiwanese patients with type 2 diabetes mellitus.
Tseng CH
Sci Rep; 2021 Jun; 11(1):12400. PubMed ID: 34117321
[TBL] [Abstract][Full Text] [Related]
8. Metformin and risk of gingival/periodontal diseases in diabetes patients: A retrospective cohort study.
Tseng CH
Front Endocrinol (Lausanne); 2022; 13():1036885. PubMed ID: 36277720
[TBL] [Abstract][Full Text] [Related]
9. The Risk of Age-Related Macular Degeneration Is Reduced in Type 2 Diabetes Patients Who Use Metformin.
Tseng CH
Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259372
[TBL] [Abstract][Full Text] [Related]
10. Chronic Metformin Therapy is Associated with a Lower Risk of Hemorrhoid in Patients with Type 2 Diabetes Mellitus.
Tseng CH
Front Pharmacol; 2020; 11():578831. PubMed ID: 33664665
[No Abstract] [Full Text] [Related]
11. Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.
Tseng CH
Oncotarget; 2017 Jan; 8(2):3042-3048. PubMed ID: 27936468
[TBL] [Abstract][Full Text] [Related]
12. Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus.
Tseng CH
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439890
[TBL] [Abstract][Full Text] [Related]
13. Metformin Use Is Associated With a Lower Incidence of Hospitalization for Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus.
Tseng CH
Front Med (Lausanne); 2020; 7():592901. PubMed ID: 33693008
[No Abstract] [Full Text] [Related]
14. Metformin Is Associated with a Lower Incidence of Benign Brain Tumors: A Retrospective Cohort Study in Patients with Type 2 Diabetes Mellitus.
Tseng CH
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680039
[No Abstract] [Full Text] [Related]
15. Effect of Metformin on Lower Urinary Tract Symptoms in Male Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study in Taiwan.
Tseng CH
World J Mens Health; 2023 Jul; 41(3):680-691. PubMed ID: 36593711
[TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients.
Tseng CH
Front Endocrinol (Lausanne); 2023; 14():1185053. PubMed ID: 37560306
[TBL] [Abstract][Full Text] [Related]
17. Pioglitazone and Risk of Chronic Obstructive Pulmonary Disease in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study.
Tseng CH
Int J Chron Obstruct Pulmon Dis; 2022; 17():285-295. PubMed ID: 35177899
[TBL] [Abstract][Full Text] [Related]
18. Vildagliptin Has a Neutral Association With Dementia Risk in Type 2 Diabetes Patients.
Tseng CH
Front Endocrinol (Lausanne); 2021; 12():637392. PubMed ID: 33995274
[TBL] [Abstract][Full Text] [Related]
19. Thiazolidinedione Use Is Associated with a Borderline Lower Risk of Multiple Myeloma and a Significantly Lower Risk of Death in Patients with Type 2 Diabetes Mellitus in Taiwan.
Tseng CH
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686552
[TBL] [Abstract][Full Text] [Related]
20. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
Tseng CH
Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
